PrEP delivery led by HIV testing counselors in Kenyan clinics

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cluster-randomized, stepped-wedge implementation study conducted in public health clinics in Kenya to introduce HIV testing services (HTS) counselor-led PrEP care. The study evaluates how a PrEP care model led by HTS counselors integrates with existing clinic workflows. Eligible participants are individuals aged 15 years or older who access services at participating facilities and are not known to have HIV at the time their data are first abstracted. The lead sponsor is the University of Washington, with collaborators from NIMH, and the clinics include Kenyatta National Hospital sites in Kisumu.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥15 years of age
* Accessing health services at participating public health facilities.
* Not known to be living with HIV prior to the visit when their clinical data is first abstracted

Where it's running

• Kenyatta National Hospital
  Kisumu, Kenya Recruiting

Study contacts

• Principal investigator: Kenneth Mugwanya, MBChB, MS, PhD — University of Washington
• Study coordinator: Clare Brown, PhD
• Email: brownce@uw.edu
• Phone: 206-543-8225

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Monthly MK-8527 to prevent HIV-1 infection

  This study will test whether taking MK-8527 once a month prevents HIV-1 better than daily oral PrEP in HIV-negative, sexually active cisgender women.

  Recruiting at 21 sites Phase 3 Merck Sharp & Dohme LLC · Homabay County, Homa Bay County and 29 other locations · NCT07071623

• Cervical screening and care options for women living with HIV who test positive for high-risk HPV

  This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.

  Recruiting University of California, San Diego · Nairobi · NCT07925307

• Psilocybin Therapy for MeUD and HIV

  This study tests whether a single psilocybin dose, paired with motivational support therapy, can help people with HIV and moderate-to-severe methamphetamine use disorder stop using methamphetamine.

  Recruiting Phase 2 University of California, San Francisco · San Francisco, California · NCT07756736

• Pharmacist-guided PEP/PrEP Access Using PEPPI Software

  This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.

  Recruiting Empowerx INC · Del Mar, California · NCT07683117

• PrEP Linkage With Immediate Medications in the Emergency Department

  This study tests starting PrEP right in the Parkland Memorial Hospital ED and linking patients to ongoing PrEP care to see if it increases PrEP uptake in Dallas.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07462611

• Voluntary HIV screening among adults in France

  This study will see which voluntary HIV testing methods adults in France use.

  Recruiting Université de Reims Champagne-Ardenne · Reims · NCT07418385

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.